# AxoGen funding: rounds and investors > AxoGen has raised $198M across 10 rounds since 2007. Investors include Mizuho Capital, Wells Fargo Securities and De Novo Ventures. Every round with its source. Source: https://millionrounds.com/company/axogen (Millionrounds; every figure on the page links to its filing or article) United States · [Funded startup](https://millionrounds.com/companies) # Who invested in *AxoGen* 10 rounds we have observed, with the 8 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it. Healthcare Medical Devices Raised 9 months ago Funding summary Updated 26 Oct 2026 **$198M** raised across 10 rounds since 2007, from 10 sources **$12M** Series C **$2.6M** Debt **$3.4M** Venture **$3.7M** Debt **$3.0M** Debt **$1.0M** Venture **$18M** Series A **$13M** Round **$18M** Round **$124M** Round - **Latest round:** Round, $124M Jan 2026 - **Led by:** Mizuho Capital and Wells Fargo Securities - **Step-up i:** 7.1× - **Investors:** 8 (2 led) See who backed them ## The funding story Each circle is a round, placed by date and sized by amount. The line above is the running total. 2007 2010 2013 2016 2019 2022 2025 **$12M** Series C **$2.6M** Debt **$3.4M** Venture **$3.0M** Debt **$1.0M** Venture **$18M** Series A **$13M** Round **$18M** Round **$124M** Round - **First round:** Series C, $12M - **Biggest round:** $124M - **Usual gap between rounds:** 12 months ## The rounds - **Jan 2026** Round **$124M** *4 new* [Mizuho Capital](https://millionrounds.com/fund/mizuho-capital) Lead [Wells Fargo Securities](https://millionrounds.com/fund/wells-fargo-securities) Lead [Canaccord Genuity](https://millionrounds.com/fund/canaccord-genuity) [Raymond James](https://millionrounds.com/fund/raymond-james) Reported by Firms' own news pages - **Aug 2015** Round **$18M** No investor was named in the report. From a historical funding record - **Feb 2015** Round **$13M** No investor was named in the report. From a historical funding record - **Aug 2013** Series A **$18M** No investor was named in the report. Reported by fiercemedicaldevices.com - **Oct 2011** Venture **$1.0M** No investor was named in the report. Reported by sec.gov SEC filing: $1.0M sold, first sale Sept 2011 - **Jun 2011** Debt **$3.0M** No investor was named in the report. Reported by sec.gov SEC filing: $3.0M sold, first sale May 2011 - **Jan 2011** Debt **$3.7M** No investor was named in the report. Reported by sec.gov SEC filing: $3.7M sold, first sale Jun 2010 - **Jan 2010** Venture **$3.4M** No investor was named in the report. Reported by sec.gov SEC filing: $3.4M sold, first sale Jan 2010 - **Jun 2009** Debt **$2.6M** No investor was named in the report. From a historical funding record SEC filing: $2.6M sold, first sale Sept 2009 - **Dec 2007** Series C **$12M** *4 new* [De Novo Ventures](https://millionrounds.com/fund/de-novo-ventures) [Accuitive Medical Ventures](https://millionrounds.com/fund/accuitive-medical-ventures) [Cardinal Partners](https://millionrounds.com/fund/cardinal-partners) [Springboard Capital](https://millionrounds.com/fund/springboard-capital) From a historical funding record ## Founders and team From the SEC filings it signed: 6 on the team. - **Brad P. Hedger** Executive Officer i - **David P. Hansen** Executive Officer i - **Gregory G. Freitag** Executive Officer, Director i - **John P. Engels** Executive Officer i - **Karen Zaderej** Executive Officer, Director i - **Mark P. Friedman** Executive Officer i On the board, as filed i *Jamie M. Grooms* *Joe M. Mandato* *John M. Harper* *Mark M. Gold* *Robert J. Rudelius* ## Who was in which round The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led. **Venture** 2010 **Debt** 2011 **Debt** 2011 **Venture** 2011 **Series A** 2013 **Round** 2015 **Round** 2015 **Round** 2026 [Mizuho Capital](https://millionrounds.com/fund/mizuho-capital) L [Wells Fargo Securities](https://millionrounds.com/fund/wells-fargo-securities) L [De Novo Ventures](https://millionrounds.com/fund/de-novo-ventures) [Accuitive Medical Ventures](https://millionrounds.com/fund/accuitive-medical-ventures) [Cardinal Partners](https://millionrounds.com/fund/cardinal-partners) [Springboard Capital](https://millionrounds.com/fund/springboard-capital) [Canaccord Genuity](https://millionrounds.com/fund/canaccord-genuity) [Raymond James](https://millionrounds.com/fund/raymond-james) ## Everyone who backed them [Mizuho Capital](https://millionrounds.com/fund/mizuho-capital) VC firm **1** round, led 1 [Wells Fargo Securities](https://millionrounds.com/fund/wells-fargo-securities) VC firm **1** round, led 1 [De Novo Ventures](https://millionrounds.com/fund/de-novo-ventures) Growth equity **1** round [Accuitive Medical Ventures](https://millionrounds.com/fund/accuitive-medical-ventures) VC firm **1** round [Cardinal Partners](https://millionrounds.com/fund/cardinal-partners) Investment bank **1** round [Springboard Capital](https://millionrounds.com/fund/springboard-capital) Investment firm **1** round [Canaccord Genuity](https://millionrounds.com/fund/canaccord-genuity) Investment firm **1** round [Raymond James](https://millionrounds.com/fund/raymond-james) Angel **1** round Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=axogen). ## Quick answers about AxoGen ### Who invested in AxoGen? AxoGen's investors include Mizuho Capital, Wells Fargo Securities, De Novo Ventures, Accuitive Medical Ventures and Cardinal Partners, and 3 more on record. Mizuho Capital led its latest round. ### How much has AxoGen raised? AxoGen has raised $198M across 10 rounds since 2007. ### When did AxoGen last raise? AxoGen's most recent round was an Undisclosed round of $124M in Jan 2026, led by Mizuho Capital. ### What was AxoGen's biggest round? Its most recent round, $124M in Jan 2026, is also its largest on record. ### Who backed AxoGen first? AxoGen's first round on record, in Dec 2007, was backed by De Novo Ventures, Accuitive Medical Ventures and Cardinal Partners and 1 others. ### What stage is AxoGen at? AxoGen's latest named round is an Undisclosed round, in Jan 2026. ### Where is AxoGen based? AxoGen is based in the United States. ### Who led AxoGen's rounds? Mizuho Capital led the Undisclosed round in 2026. ## Companies like AxoGen In the same sector, and raised in the last eighteen months. [**Star Therapeutics** $325M · Oct 2026](https://millionrounds.com/company/star-therapeutics)[**Promaxo** $106M · Oct 2026](https://millionrounds.com/company/promaxo)[**AI** $18M · Oct 2026](https://millionrounds.com/company/ai)[**Baba** $40M · Oct 2026](https://millionrounds.com/company/baba)[**Rejuvenate Bio** $13M · Oct 2026](https://millionrounds.com/company/rejuvenate-bio)[**Clinical Ink** $24M · Oct 2026](https://millionrounds.com/company/clinical-ink) ## Find investors like these Search every investor by what they have actually funded, then narrow to your stage and market. Free. Open the investor searchOr these rounds in the app